A. R. Brochado

This study examines how drug treatment affects gut microbiota communities, finding that cross-protection is more common than cross-sensitization, and that metabolic processes contribute to these community behaviors.

This study shows that the CBASS antiphage defense system in Vibrio cholerae enhances sensitivity to antifolate antibiotics and enables bacterial lysis by these drugs.

This study systematically tests drug combinations in Gram-positive bacteria, identifying many new synergies and antagonisms, including effective combinations against drug-resistant strains.

The paper identifies COM-blockers, which inhibit horizontal gene transfer in S. pneumoniae by disrupting competence without affecting growth or antibiotic activity, offering a strategy to reduce antibiotic resistance spread.